Marker Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include Sellas Life Sciences.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Sellas Life Sciences SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. | |
Founding Date | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations New York, US HQ New York, US |
Employees | Employees 888% decrease | Employees 538% decrease |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 79.1 m |
Financial | ||
Net income | Net income ($12.2m) (FY, 2025) | Net income ($26.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Sellas Life Sciences
HQ
New York, US
Employees
5↓ 38% decrease
SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies.
View company